These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2704029)
1. Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors. Bäckström R; Honkanen E; Pippuri A; Kairisalo P; Pystynen J; Heinola K; Nissinen E; Linden IB; Männistö PT; Kaakkola S J Med Chem; 1989 Apr; 32(4):841-6. PubMed ID: 2704029 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of bridged catechol-homocysteine derivatives as potential inhibitors of catechol O-methyltransferase. Lever OW; Hyman C; White HL J Pharm Sci; 1984 Sep; 73(9):1241-4. PubMed ID: 6491941 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat. Nissinen E; Lindén IB; Schultz E; Kaakkola S; Männistö PT; Pohto P Eur J Pharmacol; 1988 Aug; 153(2-3):263-9. PubMed ID: 3181288 [TBL] [Abstract][Full Text] [Related]
4. Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase. Männistö PT; Kaakkola S; Nissinen E; Linden IB; Pohto P Life Sci; 1988; 43(18):1465-71. PubMed ID: 3185103 [TBL] [Abstract][Full Text] [Related]
5. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase. Engelbrecht I; Petzer JP; Petzer A Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034 [TBL] [Abstract][Full Text] [Related]
6. Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT). Masjost B; Ballmer P; Borroni E; Zürcher G; Winkler FK; Jakob-Roetne R; Diederich F Chemistry; 2000 Mar; 6(6):971-82. PubMed ID: 10785817 [TBL] [Abstract][Full Text] [Related]
7. Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: synthesis and biological activity as catechol-O-methyltransferase inhibitors. Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ J Med Chem; 1992 Nov; 35(24):4584-8. PubMed ID: 1469689 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-O-methyltransferase. Learmonth DA; Vieira-Coelho MA; Benes J; Alves PC; Borges N; Freitas AP; da-Silva PS J Med Chem; 2002 Jan; 45(3):685-95. PubMed ID: 11806720 [TBL] [Abstract][Full Text] [Related]
9. A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols. Ovaska M; Yliniemelä A J Comput Aided Mol Des; 1998 May; 12(3):301-7. PubMed ID: 9749372 [TBL] [Abstract][Full Text] [Related]
10. Crystal Structure of Catechol O-Methyltransferase Complexed with Nitecapone. Iijima H; Takebe K; Suzuki M; Kobayashi H; Takamiya T; Saito H; Niwa N; Kuwada-Kusunose T Chem Pharm Bull (Tokyo); 2020; 68(5):447-451. PubMed ID: 32378542 [TBL] [Abstract][Full Text] [Related]
11. Biochemistry and pharmacology of catechol-O-methyltransferase inhibitors. Nissinen E; Männistö PT Int Rev Neurobiol; 2010; 95():73-118. PubMed ID: 21095460 [TBL] [Abstract][Full Text] [Related]
12. Effects of tolcapone upon soluble and membrane-bound brain and liver catechol-O-methyltransferase. Vieira-Coelho MA; Soares-da-Silva P Brain Res; 1999 Mar; 821(1):69-78. PubMed ID: 10064789 [TBL] [Abstract][Full Text] [Related]
13. Bisubstrate inhibitors for the enzyme catechol-O-methyltransferase (COMT): influence of inhibitor preorganisation and linker length between the two substrate moieties on binding affinity. Lerner C; Masjost B; Ruf A; Gramlich V; Jakob-Roetne R; Zürcher G; Borroni E; Diederich F Org Biomol Chem; 2003 Jan; 1(1):42-9. PubMed ID: 12929389 [TBL] [Abstract][Full Text] [Related]
14. Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat. Männistö PT; Tuomainen P; Tuominen RK Br J Pharmacol; 1992 Mar; 105(3):569-74. PubMed ID: 1628144 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of catechol-O-methyltransferase by N-(3,4-dihydroxyphenyl) maleimide. Piedrafita FJ; Elorriaga C; Fernández-Alvarez E; Nieto O J Enzyme Inhib; 1990; 4(1):43-50. PubMed ID: 2128841 [TBL] [Abstract][Full Text] [Related]
16. Development of Blood-Brain Barrier Permeable Nitrocatechol-Based Catechol O-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity. Silva T; Mohamed T; Shakeri A; Rao PP; Martínez-González L; Pérez DI; Martínez A; Valente MJ; Garrido J; Uriarte E; Serrão P; Soares-da-Silva P; Remião F; Borges F J Med Chem; 2016 Aug; 59(16):7584-97. PubMed ID: 27463695 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of catechol-O-methyltransferase by 6,7-dihydroxy-3,4-dihydroisoquinolines related to dopamine: demonstration using liquid chromatography and a novel substrate for O-methylation. Cheng BY; Origitano TC; Collins MA J Neurochem; 1987 Mar; 48(3):779-86. PubMed ID: 2433397 [TBL] [Abstract][Full Text] [Related]
18. Chemical synthesis and characterization of conjugates of a novel catechol-O-methyltransferase inhibitor. Learmonth DA; Freitas AP Bioconjug Chem; 2002; 13(5):1112-8. PubMed ID: 12236793 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase. Lautala P; Ulmanen I; Taskinen J Mol Pharmacol; 2001 Feb; 59(2):393-402. PubMed ID: 11160877 [TBL] [Abstract][Full Text] [Related]